HOME >> MEDICINE >> NEWS
Envisat Symposium report day 4: Assistance from space to combat hazards and natural disasters

When is a flood not a flood? For the duration of the International Humanitarian Partnership's Triplex 2004 exercise, taking place in Norway this week, humanitarian aid groups are taking part in a scenario where the country's southern Lake Mjǿsa is in fact a flood zone in the imaginary country of 'Innlandia', inundated by a combination of heavy rainfall and a neglected dam that has given way. Within the context of the exercise, 100 000 people have been affected by the disaster, with 1000 people stranded on an island actually the real semi-island of Helgǿya - needing assistance and evacuation.

In this imaginary setting, real international aid groups arrive to give help, with participants including Norway's Directorate for Civil Protection and Emergency Planning, the United Nations High Commissioner for Refugees, the UK's Department for International Development and the International Red Cross.

More than 350 people from 20 different organisations have gathered at the Starum Civil Defence training centre to take part in the Triplex exercise and at the centre of their activities is an image from Envisat.

"We have supplied the participants with a damage assessment map based on an Envisat Advanced Synthetic Aperture Radar (ASAR) map acquired on Tuesday," explained Einar Bjorgo of UNOSAT, an organisation that procures satellite imagery for United Nations organisations, supported by ESA through its Earth Observation Market Development (EOMD) Programme.

"Working in cooperation with our partners MapAction, we overlaid a previously prepared pre-disaster simulated image with the ASAR-derived lake area, preparing a damage assessment map for distribution and use in the field during Triplex."

Use of satellite imagery to coordinate disaster relief is hardly limited to training exercises, as Symposium participants have learnt. UNOSAT and MapAction are both partners in the RESPOND consortium, an ESA-backed project to supply s
'"/>

Contact: Mariangela D'Acunto
mariangela.d'acunto@esa.int
39-06-941-80-856
European Space Agency
10-Sep-2004


Page: 1 2 3 4

Related medicine news :

1. Envisat enables first global check of regional methane emissions
2. Global air pollution map produced by Envisats SCIAMACHY
3. Envisat Symposium report day 3: Satellites supporting Kyoto - our future is in our forests
4. Envisat Symposium report day 2: GMES turns science to services
5. Envisat Symposium day one: Steady symphony of Europes largest satellite
6. Taking apart a hurricane: Multi-sensor Envisat sees through Frances
7. Envisat witnesses return of the South Polar ozone hole
8. Scientists meet to review Envisat results after two and a half years of operations
9. Envisats rainbow vision detects ground moving at pace fingernails grow
10. Envisat images delivered to Antarctic eclipse spotters
11. Near-real time ozone forecasting made possible by Envisat

Post Your Comments:
(Date:6/19/2013)... Salt Lake City, UT (PRWEB) June 19, 2013 ... wellness companies : , In July 2013, Orriant ... optimize their participation rates, and maintain compliance with ... implemented allowing employees to receive wellness incentives if ... Orriant has announced they have been compliant with ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 As ... cancer continue to mount in courts throughout the U.S., ... Drug Administration (FDA) recently held a meeting to discuss ... as incretin mimetics. According to a June 12th ... from the makers of Januvia and similar drugs, following ...
(Date:6/19/2013)... In what is believed to be the largest follow-up ... hereditary dystonia a movement disorder that can cause ... report good success rates and lasting benefits. , Michele ... at Cedars-Sinai Medical Center,s Department of Neurology, and Ron ... at Beth Israel Deaconess Medical Center in Boston, published ...
(Date:6/19/2013)... disparities between minority and white clients in success ... these disparities vary widely from state to state. ... states there,s something amiss," says Stephan Arndt, Ph.D., ... strong racial and ethnic disparities for people in ... successfully, and those disparities are something we need ...
(Date:6/19/2013)... The Movement Disorders Center ... urologists with specialists in physical therapy, occupational therapy ... and their family members to manage diseases and ... also have the opportunity to participate in the ... disorders can be relentlessly progressive and disabling conditions, ...
Breaking Medicine News(10 mins):Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3Health News:Abington Memorial Hospital’s Neurosciences Institute Opens Movement Disorders Center 2
(Date:6/19/2013)... MUMBAI, India , June 19, ... Book Bureau has recently added DrugPatentWatch ... Databases. ( http://www.bharatbook.com/drugpatentwatch-tour.pdf ) ... DrugPatentWatch provides comprehensive information on pharmaceutical, ... value-added information supports the critical business ...
(Date:6/19/2013)... --  Nektar Therapeutics (Nasdaq: NKTR ) today ... study for NKTR-181, a first-in-class, opioid analgesic molecule ... slow rate of entry is designed to reduce the euphoria ... current opioid analgesics. 1 In the study data being ... in "drug liking" and "feeling high" scores and had highly ...
(Date:6/19/2013)... June 19, 2013 BD Biosciences, a segment of ... a leading global medical technology company, today announced the launch ... latest in its line of high-performance research flow cytometers. ... multicolor analysis with the most compact footprint in its class ... a height of 30" (76.2 cm). Recognizing that space is ...
Breaking Medicine Technology:Drug Patent Watch 2Drug Patent Watch 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2
Cached News: